|
gptkbp:instanceOf
|
psychedelic phenethylamine
|
|
gptkbp:chemicalClass
|
gptkb:2C_family
amphetamine
|
|
gptkbp:chemicalFormula
|
C11H17NO2S
|
|
gptkbp:color
|
white
|
|
gptkbp:discoveredBy
|
gptkb:Alexander_Shulgin
|
|
gptkbp:duration_of_effects
|
6–10 hours
|
|
gptkbp:effect
|
psychedelic
hallucinogenic
entactogenic
|
|
gptkbp:excretion
|
renal
|
|
gptkbp:featuredIn
|
gptkb:PiHKAL
|
|
gptkbp:firstSynthesized
|
1981
|
|
gptkbp:form
|
powder
|
|
gptkbp:hasSMILES
|
CCSC1=CC(OC)=C(CCN)C=C1OC
|
|
gptkbp:hasStreet
|
gptkb:T-2
Rosy
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
2C-T-2
|
|
gptkbp:IUPACName
|
2-(4-ethylthio-2,5-dimethoxyphenyl)ethanamine
|
|
gptkbp:legal_status_in_Canada
|
gptkb:Schedule_III
|
|
gptkbp:legal_status_in_United_Kingdom
|
Class A drug
|
|
gptkbp:legal_status_in_United_States
|
Schedule I controlled substance
|
|
gptkbp:meltingPoint
|
140–142 °C
|
|
gptkbp:metabolism
|
hepatic
|
|
gptkbp:molecularWeight
|
227.32 g/mol
|
|
gptkbp:otherName
|
gptkb:2C-T-2
gptkb:2,5-Dimethoxy-4-ethylthiophenethylamine
gptkb:2,5-dimethoxy-4-ethylthiophenethylamine
|
|
gptkbp:PubChem_CID
|
2746956
|
|
gptkbp:relatedTo
|
gptkb:2C-T-7
gptkb:2C-E
gptkb:2C-B
|
|
gptkbp:riskFactor
|
nausea
anxiety
overdose
hallucinations
vasoconstriction
|
|
gptkbp:routeOfAdministration
|
oral
insufflation
|
|
gptkbp:toxicity
|
not well studied
|
|
gptkbp:UNII
|
6QK1I1W1V6
|
|
gptkbp:used_recreationally
|
yes
|
|
gptkbp:bfsParent
|
gptkb:2D0T
gptkb:2C_family
|
|
gptkbp:bfsLayer
|
7
|